A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide

PHASE2

Phase

RECRUITING

Status

Enrollment

OTHER

Sponsor class

Conditions

DRUG: Alpibectir 45 mg once daily (OD) plus Ethionamide 125 mg OD
DRUG: Alpibectir 45 mg OD plus Ethionamide 250 mg OD
DRUG: Isoniazid, rifampicin, pyrazinamide and ethambutol fixed dose combination, weight based
DRUG: Alpibectir 45 mg OD plus Ethionamide 250 mg OD plus Rifampicin 10 mg/kg OD plus Ethambutol 20 mg/kg OD plus Pyrazinamide 25 mg/kg OD

TASK Applied Science